1. Home
  2. BLRX vs WKHS Comparison

BLRX vs WKHS Comparison

Compare BLRX & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • WKHS
  • Stock Information
  • Founded
  • BLRX 2003
  • WKHS 2007
  • Country
  • BLRX Israel
  • WKHS United States
  • Employees
  • BLRX N/A
  • WKHS N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • WKHS Auto Manufacturing
  • Sector
  • BLRX Health Care
  • WKHS Consumer Discretionary
  • Exchange
  • BLRX Nasdaq
  • WKHS Nasdaq
  • Market Cap
  • BLRX 17.1M
  • WKHS 17.4M
  • IPO Year
  • BLRX 2011
  • WKHS N/A
  • Fundamental
  • Price
  • BLRX N/A
  • WKHS $1.11
  • Analyst Decision
  • BLRX Strong Buy
  • WKHS Hold
  • Analyst Count
  • BLRX 2
  • WKHS 2
  • Target Price
  • BLRX $19.00
  • WKHS $8.68
  • AVG Volume (30 Days)
  • BLRX 52.2K
  • WKHS 1.3M
  • Earning Date
  • BLRX 11-24-2025
  • WKHS 11-18-2025
  • Dividend Yield
  • BLRX N/A
  • WKHS N/A
  • EPS Growth
  • BLRX N/A
  • WKHS N/A
  • EPS
  • BLRX N/A
  • WKHS N/A
  • Revenue
  • BLRX $17,251,000.00
  • WKHS $10,745,014.00
  • Revenue This Year
  • BLRX N/A
  • WKHS $92.70
  • Revenue Next Year
  • BLRX N/A
  • WKHS $34.00
  • P/E Ratio
  • BLRX N/A
  • WKHS N/A
  • Revenue Growth
  • BLRX 1.19
  • WKHS 11.73
  • 52 Week Low
  • BLRX $2.30
  • WKHS $0.81
  • 52 Week High
  • BLRX $22.60
  • WKHS $24.25
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 69.50
  • WKHS 36.14
  • Support Level
  • BLRX $3.57
  • WKHS $1.05
  • Resistance Level
  • BLRX $4.56
  • WKHS $1.24
  • Average True Range (ATR)
  • BLRX 0.27
  • WKHS 0.07
  • MACD
  • BLRX 0.08
  • WKHS 0.01
  • Stochastic Oscillator
  • BLRX 87.13
  • WKHS 19.95

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About WKHS Workhorse Group Inc.

Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.

Share on Social Networks: